ECSP18071568A - MICROBIAL DIRECT SUPPLY AGENT FOR THE PREVENTION OF A PATHOLOGY OF SHRIMP - Google Patents

MICROBIAL DIRECT SUPPLY AGENT FOR THE PREVENTION OF A PATHOLOGY OF SHRIMP

Info

Publication number
ECSP18071568A
ECSP18071568A ECSENADI201871568A ECDI201871568A ECSP18071568A EC SP18071568 A ECSP18071568 A EC SP18071568A EC SENADI201871568 A ECSENADI201871568 A EC SENADI201871568A EC DI201871568 A ECDI201871568 A EC DI201871568A EC SP18071568 A ECSP18071568 A EC SP18071568A
Authority
EC
Ecuador
Prior art keywords
shrimp
pathology
prevention
direct supply
supply agent
Prior art date
Application number
ECSENADI201871568A
Other languages
Spanish (es)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of ECSP18071568A publication Critical patent/ECSP18071568A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/07—Bacillus
    • C12R2001/125—Bacillus subtilis ; Hay bacillus; Grass bacillus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Polymers & Plastics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Husbandry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Physiology (AREA)
  • Insects & Arthropods (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La presente invención se refiere a cepas de Bacillus subtilis y su uso para el tratamiento de una patología del camarón tal como el síndrome de mortalidad temprana.The present invention relates to Bacillus subtilis strains and their use for the treatment of a shrimp pathology such as early mortality syndrome.

ECSENADI201871568A 2016-02-23 2018-09-21 MICROBIAL DIRECT SUPPLY AGENT FOR THE PREVENTION OF A PATHOLOGY OF SHRIMP ECSP18071568A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662298578P 2016-02-23 2016-02-23

Publications (1)

Publication Number Publication Date
ECSP18071568A true ECSP18071568A (en) 2018-10-31

Family

ID=58231730

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSENADI201871568A ECSP18071568A (en) 2016-02-23 2018-09-21 MICROBIAL DIRECT SUPPLY AGENT FOR THE PREVENTION OF A PATHOLOGY OF SHRIMP

Country Status (3)

Country Link
CN (1) CN108603166A (en)
EC (1) ECSP18071568A (en)
WO (1) WO2017147130A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019040266A1 (en) * 2017-08-23 2019-02-28 Novozymes A/S Direct fed microbials for improving the general condition and health of fish
WO2019132605A1 (en) * 2017-12-29 2019-07-04 씨제이제일제당 (주) Feed composition containing bacilius subtilus strain as active ingredient for preventing or treating acute hepatopancreatic necrosis disease or white spot syndrome
KR102277987B1 (en) * 2017-12-29 2021-07-16 씨제이제일제당 주식회사 A feed composition for the preventing or treating Acute Hepatopancreatic Necrosis Disease or White Spot Syndrome including Bacillus subtilus, Bacillus pumilus, and Bacillus licheniformis
GB201911925D0 (en) * 2019-08-20 2019-10-02 Sporegen Ltd Formulations for prevention or reduction of c. difficile infections
CN111690558B (en) * 2020-05-31 2022-04-08 青岛玛斯特生物技术有限公司 Bacillus subtilis strain and application thereof in aquaculture
CN112251370B (en) * 2020-09-03 2023-08-04 福建大北农华有水产科技集团有限公司 Composite microecological preparation containing bacillus subtilis and application thereof
CN112602859A (en) * 2020-12-28 2021-04-06 东台市苏泰饲料有限公司 Feed for preventing and controlling hepatopancreas necrosis syndrome of prawns
CN116286447A (en) * 2022-10-09 2023-06-23 集美大学 Bacillus subtilis and application thereof
CN116948890B (en) * 2023-07-13 2024-03-22 江苏三仪生物工程有限公司 Composite microecological microbial agent for inhibiting vibrio aquiculture and preparation method thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013155468A2 (en) * 2012-04-12 2013-10-17 Dupont Nutrition Biosciences Aps Microbial strains and their use in animals

Also Published As

Publication number Publication date
WO2017147130A2 (en) 2017-08-31
WO2017147130A3 (en) 2017-10-19
CN108603166A (en) 2018-09-28

Similar Documents

Publication Publication Date Title
ECSP18071568A (en) MICROBIAL DIRECT SUPPLY AGENT FOR THE PREVENTION OF A PATHOLOGY OF SHRIMP
CL2016002027A1 (en) Cyclopropylamine as an inhibitor of lsd1
CL2017003404A1 (en) Antibacterial compounds
CL2018001358A1 (en) Compositions comprising bacterial strains
CO2017013443A2 (en) Compositions comprising bacterial strains of the genus Blautia
CO2017013446A2 (en) Compositions comprising bacterial strains of the genus Bacteroides
CL2016001933A1 (en) Compounds derived from macrocycles, inhibitors of the factor xia pharmaceutical composition that comprises them and their use in the treatment and prophylaxis of a thromboembolic disease. pct
CO2018013557A2 (en) Compositions comprising bacterial strains
CL2017003142A1 (en) Compositions comprising bacterial strains
CL2016002516A1 (en) "Substituted spirocycle derived compounds, atx inhibitors; pharmaceutical composition comprising them; and its use in the treatment of cancer, inflammations, neuropathic pain, fibrotic diseases, thrombosis, among others ”. pct
CL2018002698A1 (en) Treatment of inflammatory diseases with c5a activity inhibitors
SV2017005461A (en) BENZAMIDS REPLACED WITH 1,3-TIAZOL-2-ILO
ECSP21033236A (en) COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CONDITIONS ASSOCIATED WITH THE ACTIVITY OF NLRP
CO2020007142A2 (en) Compositions and methods for the treatment of immune disorders using strains of lactococcus immunomodulatory bacteria
UY35916A (en) TRICYCLIC COMPOUNDS AS BROMODOMINUM INHIBITING ANTINEOPLASTIC AGENTS
CL2016002091A1 (en) Triazine compound and its use for medicinal purposes
CL2019003398A1 (en) Pyrazole magl inhibitors.
CL2016003074A1 (en) Compounds derived from 2-oxy-2-phenyl-n-5-pyrrolidin-3-ylamino-1,3,4-thiadiazol-2-ylacetamide, pharmaceutical composition gls1 inhibitors and their use to treat cancer.
DOP2016000170A (en) COMPOUNDS DERIVED FROM HYDROXIFORMAMIDE AND USES OF THE SAME
CL2017000845A1 (en) Lysine Gingipain Inhibitors
CL2017002451A1 (en) Novel heterocyclic compounds and their use in the prevention or treatment of bacterial infections
MX360084B (en) Shampoo composition comprising gel matrix and histidine.
CO2018012180A2 (en) Treatment methods for cholestatic and fibrotic diseases
CL2017002803A1 (en) Heterocyclic compounds and their use in the prevention or treatment of bacterial infections
AR103323A1 (en) GLUCAGON DERIVATIVES